CONCENTRAID

LOE Approaching

desmopressin acetate

NDANASALSOLUTION
Approved
Dec 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

acetate's primary pharmacodynamic action involves its binding to vasopressin 2 (V2) receptors. V2 receptors are primarily located in the distal convoluted tubule and collecting ducts of the nephron in the kidneys. These receptors play a crucial role in regulating water reabsorption and urine…

Clinical Trials (1)

NCT00835211Phase 1Completed

Desmopressin Acetate 0.2 mg Tablets, Fasting

Started Jul 2003
48 enrolled
Healthy